News Focus
News Focus
icon url

XFundManager

07/29/22 1:22 PM

#37303 RE: boston745 #37299

We have incurred net losses since our inception and may never achieve or sustain profitability.
icon url

XFundManager

07/29/22 1:27 PM

#37306 RE: boston745 #37299

Risks Related to Our Common Stock

The price of our common stock is volatile and is likely to continue to fluctuate.
Securities analysts may not continue to provide coverage of our common stock or may issue negative reports, which may have a negative impact on the market price of our common stock.

Anti-takeover provisions in our organizational documents and Delaware law may discourage or prevent a change in control, which could affect our stock price adversely and prevent attempts by our stockholders to replace or remove our current management.

We do not intend to pay cash dividends.
Our outstanding shares of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock and our outstanding common stock warrants are convertible and exercisable into shares of our common stock and when converted or exercised, the issuance of additional shares of common stock may result in downward pressure on the trading price of our common shares.
icon url

XFundManager

07/29/22 1:31 PM

#37307 RE: boston745 #37299

SINT I.P is of ZERO VALUE !


If our patents, trade secrets and contractual provisions are inadequate to protect our intellectual property, we may not be able to successfully commercialize our products or operate our business profitably.

We have no patent protection covering the composition of matter for our solid silicon nitride or components of the related manufacturing process, and competitors may create formulations or processes substantially similar to ours.

We could become subject to intellectual property litigation that could consume significant amounts of our resources and adversely affect our business and results of operations.

We may be subject to damages resulting from claims that we have wrongfully used or disclosed alleged trade secrets of our competitors or are in breach of non-competition agreements with our competitors or non-solicitation agreements.

If our advanced ceramic products or our product candidates’ conflict with the rights of others, we may not be able to manufacture or market our products or product candidates.

icon url

joev2

07/29/22 1:41 PM

#37310 RE: boston745 #37299

Management (and others) not buying says another thing: it's not worth buying. A good trading stock has a lot of volume and movement: Sint has neither.

As for management being complicit, who's management (other than Bal)?

You continually harp on the IP's value.....and yet no one sees it....for years! This is why management (and everyone else) doesn't buy. As for actual IP value, it doesn't matter IF the product is too difficult to sell, produce, get needed approval etc etc. Until it becomes the 'in' thing, you're watching your cash dwindle more and more, because Sonny will continue collecting regardless, and the company will stay alive without producing, but the retail investor?

How long was it before the electric car became 'the thing'? How long did Ford and others keep it under wraps (knowing it was a viable alternative to their own)? So even assuming it's the same deal with Sint, right now everyone BUT retail, knows it's not ready for prime time, regardless the reasoning as to why.

The only winners here are those getting paid for negligible results and those who have not invested. You'll always have an occasional short or trader....doesn't matter the company.